Authors

• Peter Luo (ORCID: https://orcid.org/0000-0001-5719-1897)
• Jeeyun Lee (ORCID: https://orcid.org/0000-0002-4911-6165)
• Songmao Zheng (ORCID: https://orcid.org/0000-0002-7727-0928)
• Dana D. Hu‐Lowe
• Daneng Li (ORCID: https://orcid.org/0000-0001-5330-7522)
• Michael Chisamore (ORCID: https://orcid.org/0009-0006-8629-8232)
• Kristine Xiaohong She
• Sang Joon Shin (ORCID: https://orcid.org/0000-0001-5350-7241)
• Marwan Fakih (ORCID: https://orcid.org/0000-0002-6554-5488)
• Sun Young Kim (ORCID: https://orcid.org/0000-0002-5886-3920)
• Yan Li (ORCID: https://orcid.org/0000-0001-6459-4483)
• Hee Kyung Kim (ORCID: https://orcid.org/0000-0001-7416-4727)
• Ping Xiao (ORCID: https://orcid.org/0000-0002-0134-189X)
• Jiangchun Xu
• Manish Patel (ORCID: https://orcid.org/0000-0003-1134-1591)
• Sunil Sharma
• Stanley R. Frankel
• Luke Chung (ORCID: https://orcid.org/0000-0002-0260-9069)
• Jiping Zha
• Sae Won Han

Institutions

• Ulsan College (KR)
• Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
• City Of Hope National Medical Center (US)
• Asan Medical Center (KR)
• Samsung Medical Center (KR)
• Seoul National University Hospital (KR)
• University of Ulsan (KR)
• Sarah Cannon (US)
• City of Hope (US)
• HonorHealth (US)
• Yonsei University Health System (KR)
• Sungkyunkwan University (KR)

Publication Details

Journal

Journal of Clinical Oncology

Published

2025-05-28

DOI

https://doi.org/10.1200/jco.2025.43.16_suppl.3579

Citations

1

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

1.05